JP2008542237A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008542237A5 JP2008542237A5 JP2008512825A JP2008512825A JP2008542237A5 JP 2008542237 A5 JP2008542237 A5 JP 2008542237A5 JP 2008512825 A JP2008512825 A JP 2008512825A JP 2008512825 A JP2008512825 A JP 2008512825A JP 2008542237 A5 JP2008542237 A5 JP 2008542237A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- topiramate
- composition according
- organic solvent
- peg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05104491 | 2005-05-25 | ||
| US69039105P | 2005-06-14 | 2005-06-14 | |
| PCT/EP2006/062518 WO2006125774A1 (en) | 2005-05-25 | 2006-05-23 | Pediatric formulation of topiramate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008542237A JP2008542237A (ja) | 2008-11-27 |
| JP2008542237A5 true JP2008542237A5 (enExample) | 2009-07-09 |
Family
ID=35045349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008512825A Withdrawn JP2008542237A (ja) | 2005-05-25 | 2006-05-23 | トピラメートの小児科用製剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060270611A1 (enExample) |
| EP (1) | EP1888030A1 (enExample) |
| JP (1) | JP2008542237A (enExample) |
| CN (1) | CN101257889A (enExample) |
| AR (1) | AR053737A1 (enExample) |
| AU (1) | AU2006251213A1 (enExample) |
| BR (1) | BRPI0610210A2 (enExample) |
| CA (1) | CA2609719A1 (enExample) |
| MX (1) | MX2007014713A (enExample) |
| RU (1) | RU2007148444A (enExample) |
| TW (1) | TW200716202A (enExample) |
| WO (1) | WO2006125774A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2246044A1 (en) * | 2009-04-21 | 2010-11-03 | Pierre Fabre Dermo-Cosmétique | Paediatric solutions comprising a beta-blocker |
| JP5840201B2 (ja) | 2010-05-10 | 2016-01-06 | ユーロ−セルティーク エス．エイ． | 活性剤を負荷した顆粒と追加の活性剤の組合せ |
| ES2642788T3 (es) | 2010-05-10 | 2017-11-20 | Euro-Celtique S.A. | Fabricación de gránulos sin principio activo y de comprimidos que comprenden los mismos |
| CA2795324C (en) * | 2012-11-09 | 2015-07-14 | Purdue Pharma | Pharmaceutical compositions comprising hydromorphone and naloxone |
| US9549909B2 (en) | 2013-05-03 | 2017-01-24 | The Katholieke Universiteit Leuven | Method for the treatment of dravet syndrome |
| EP3068397A1 (en) | 2013-11-13 | 2016-09-21 | Euro-Celtique S.A. | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome |
| CN104188920A (zh) * | 2014-07-28 | 2014-12-10 | 安徽省逸欣铭医药科技有限公司 | 托吡酯颗粒剂及其制备方法 |
| PT3340971T (pt) * | 2015-08-24 | 2024-06-05 | Zogenix International Ltd | Métodos de tratamento da síndrome de lennox-gastaut com utilização de fenfluramina |
| US9901576B2 (en) | 2015-11-20 | 2018-02-27 | West-Ward Pharmaceuticals International Limited | Stable formulation of phenobarbital sodium injection |
| JP2019507111A (ja) | 2015-12-22 | 2019-03-14 | ゾゲニクス インターナショナル リミテッド | 代謝抵抗性フェンフルラミン類縁体およびその使用法 |
| KR102688278B1 (ko) | 2015-12-22 | 2024-07-26 | 조게닉스 인터내셔널 리미티드 | 펜플루라민 조성물 및 그 제조 방법 |
| CA3032996C (en) | 2016-08-24 | 2025-05-06 | Zogenix International Ltd | Formulation for inhibiting formation of 5-ht 2b agonists and methods of using same |
| US10682317B2 (en) | 2017-09-26 | 2020-06-16 | Zogenix International Limited | Ketogenic diet compatible fenfluramine formulation |
| WO2019186515A1 (en) * | 2018-03-30 | 2019-10-03 | Ftf Pharma Private Limited | Liquid pharmaceutical compositions of antiepileptic drugs |
| CA3097335A1 (en) | 2018-05-11 | 2019-11-14 | Zogenix International Limited | Compositions and methods for treating seizure-induced sudden death |
| WO2019241005A1 (en) | 2018-06-14 | 2019-12-19 | Zogenix International Limited | Compositions and methods for treating respiratory depression with fenfluramine |
| GB2596184A (en) * | 2018-09-13 | 2021-12-22 | Ftf Pharma Private Ltd | Non-aqueous solutions for oral dosage |
| AU2019384963B2 (en) | 2018-11-19 | 2022-05-26 | Zogenix International Limited | Methods of treating Rett syndrome using fenfluramine |
| WO2020104837A1 (en) | 2018-11-21 | 2020-05-28 | Rosemont Pharmaceuticals Limited | Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability |
| US20210169844A1 (en) * | 2019-12-10 | 2021-06-10 | Tulex Pharmaceuticals Inc. | Compositions and methods for treating epilepsy, seizures and other conditions |
| GB2594242A (en) * | 2020-04-14 | 2021-10-27 | Syri Ltd | A stable and ready to administer liquid pharmaceutical composition of topiramate |
| US11612574B2 (en) | 2020-07-17 | 2023-03-28 | Zogenix International Limited | Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| CN117159458A (zh) * | 2022-05-27 | 2023-12-05 | 北京万全德众医药生物技术有限公司 | 托吡酯口服溶液及其制备方法 |
| US12109188B1 (en) | 2023-03-24 | 2024-10-08 | Tap Pharmaceuticals Ag | Liquid pharmaceutical formulations of topiramate |
| US12290504B2 (en) | 2023-04-11 | 2025-05-06 | Tap Pharmaceuticals Ag | Aqueous formulations of topiramate |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| AU651244B2 (en) * | 1991-09-19 | 1994-07-14 | Mcneilab, Inc. | Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol |
| US20030077227A1 (en) * | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| JP2004331502A (ja) * | 2001-06-18 | 2004-11-25 | Ortho Mcneil Pharmaceut Inc | 視神経細胞保護剤 |
| US6559293B1 (en) * | 2002-02-15 | 2003-05-06 | Transform Pharmaceuticals, Inc. | Topiramate sodium trihydrate |
| US20050129765A1 (en) * | 2003-11-14 | 2005-06-16 | Shaoling Li | Controlled release of topiramate in liquid dosage forms |
-
2006
- 2006-05-23 JP JP2008512825A patent/JP2008542237A/ja not_active Withdrawn
- 2006-05-23 RU RU2007148444/15A patent/RU2007148444A/ru not_active Application Discontinuation
- 2006-05-23 AU AU2006251213A patent/AU2006251213A1/en not_active Abandoned
- 2006-05-23 MX MX2007014713A patent/MX2007014713A/es not_active Application Discontinuation
- 2006-05-23 CA CA002609719A patent/CA2609719A1/en not_active Abandoned
- 2006-05-23 US US11/419,834 patent/US20060270611A1/en not_active Abandoned
- 2006-05-23 WO PCT/EP2006/062518 patent/WO2006125774A1/en not_active Ceased
- 2006-05-23 BR BRPI0610210-7A patent/BRPI0610210A2/pt not_active IP Right Cessation
- 2006-05-23 EP EP06755288A patent/EP1888030A1/en not_active Withdrawn
- 2006-05-23 CN CNA2006800178845A patent/CN101257889A/zh active Pending
- 2006-05-24 TW TW095118344A patent/TW200716202A/zh unknown
- 2006-05-24 AR ARP060102160A patent/AR053737A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008542237A5 (enExample) | ||
| AU720132B2 (en) | Pharmaceutical compositions | |
| CA2359813A1 (en) | Nicotine mucosal spray | |
| WO2007070504A3 (en) | Stable and palatable oral liquid sumatriptan compositions | |
| WO2005117911A3 (en) | Taste-masked formulations containing sertraline and sulfoalkyl ether cyclodextrin | |
| JP2010513487A5 (enExample) | ||
| RU2007148444A (ru) | Педиатрическая композиция топирамата | |
| WO2008143240A1 (ja) | 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法 | |
| JP2015527385A5 (enExample) | ||
| RU2488393C2 (ru) | Жидкие композиции, включающие валсартан | |
| JP2014530801A5 (enExample) | ||
| RU2015102575A (ru) | Жидкие композиции рацекадотрила | |
| JP2013500322A5 (enExample) | ||
| JP2006516272A5 (enExample) | ||
| WO2002009731A1 (fr) | Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches | |
| RU2014101990A (ru) | Жидкая фармацевтическая композиция, включающая нитизинон | |
| CA3127926A1 (en) | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa | |
| RU2008118150A (ru) | Снижение солености с помощью подсластителей | |
| RU2015134148A (ru) | Галеновая форма для введения активного действующего вещества | |
| WO2005065429B1 (en) | Composition and method for treatment of hepatic encephalopathy | |
| JP2015536995A5 (enExample) | ||
| TW200911302A (en) | Pharmaceutical solutions | |
| JP2005535644A5 (enExample) | ||
| CN103458874A (zh) | 对组合物的改进和与组合物有关的改进 | |
| JP5776355B2 (ja) | 内服液剤 |